2012
DOI: 10.1002/ajmg.a.35529
|View full text |Cite
|
Sign up to set email alerts
|

Anthropometric measurements in Egyptian patients with osteogenesis imperfecta

Abstract: Osteogenesis imperfecta (OI) is a heritable skeletal disorder with bone fragility and often short stature. This study provides anthropometric measurements in Egyptian children with OI and determine variability among OI types classified according to Sillence et al. [Sillence et al. (1979); J Med Genet 16:101-116]. The study included 124 patients with OI. All were subjected to full clinical and radiological examination. Accordingly they were classified into types OI-I (N = 16), OI-III (N = 86), and OI-IV (N = 22… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

8
7
1
2

Year Published

2014
2014
2019
2019

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 12 publications
(18 citation statements)
references
References 28 publications
8
7
1
2
Order By: Relevance
“…The mean Ht SDS in both OI-III and OI-IV was below -2.5 SDS with a significant difference between OI-I and both OI-III and OI-IV, while a nonsignificant difference was detected between OI-III and OI-IV (p = 0.21). Our results of length and Ht SDSs in OI patients were in agreement with other studies [10,26,27,28] which found that many patients with OI-I and few with OI-IV had a Ht SDS within the reference interval, in contrast to those with OI-III who were mostly shorter than reference ranges.…”
Section: Discussionsupporting
confidence: 82%
See 4 more Smart Citations
“…The mean Ht SDS in both OI-III and OI-IV was below -2.5 SDS with a significant difference between OI-I and both OI-III and OI-IV, while a nonsignificant difference was detected between OI-III and OI-IV (p = 0.21). Our results of length and Ht SDSs in OI patients were in agreement with other studies [10,26,27,28] which found that many patients with OI-I and few with OI-IV had a Ht SDS within the reference interval, in contrast to those with OI-III who were mostly shorter than reference ranges.…”
Section: Discussionsupporting
confidence: 82%
“…It was suggested that in OI patients, combined growth hormone/bisphosphonate therapy improves bone mineral density, lumbar spine projected area, and growth velocity, particularly in severe cases [35]. In agreement with another study [28], the present study showed that mean Wt and BMI SDSs for all patients lay within the normal range. However, underweight and obesity were detected in 17.86 and 5.36% of patients with OI-III, respectively.…”
Section: Discussionsupporting
confidence: 80%
See 3 more Smart Citations